Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Alimera SciencesAddex TherapeuticsMoleculin BiotechRegeneRx BiopharmaceuticalsAkari Therapeutics
SymbolNASDAQ:ALIMOTCMKTS:ADDXFNASDAQ:MBRXOTCMKTS:RGRXNASDAQ:AKTX
Price Information
Current Price$3.80$1.70$0.57$0.19$1.29
52 Week RangeBuyN/ABuyN/ABuy
Analyst Ratings
Consensus RecommendationBuyN/ABuyN/ABuy
Consensus Price Target$30.00N/A$2.50N/A$5.00
% Upside from Price Target689.47% upsideN/A338.60% upsideN/A287.60% upside
Trade Information
Market Cap$17.08 million$44.83 million$30.34 million$24.82 million$20.46 million
Beta2.120.41.590.48-1.34
Average Volume18,503N/A2,729,69672,673140,548
Sales & Book Value
Annual Revenue$53.94 millionN/AN/A$80,000.00N/A
Price / Sales0.35N/AN/A321.92N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($7.01) per shareN/A$0.34 per share($0.02) per share$0.20 per share
Price / Book-0.54N/AN/A-9.65N/A
Profitability
Net Income$-10,440,000.00N/A$-13,200,000.00$-1,400,000.00$-16,470,000.00
EPS($2.19)N/A($0.32)N/A($0.93)
Trailing P/E RatioN/A0.00N/A0.00N/A
Forward P/E Ratio5.35N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-19.36%N/AN/A-1,844.05%N/A
Return on Equity (ROE)N/AN/A-87.56%N/A-908.42%
Return on Assets (ROA)-20.93%N/A-57.40%-151.91%-172.70%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.02%N/AN/A
Current Ratio2.72%N/A3.78%2.82%1.43%
Quick Ratio2.60%N/A3.78%2.82%1.43%
Ownership Information
Institutional Ownership Percentage30.37%N/A10.20%0.18%14.96%
Insider Ownership Percentage14.60%N/A11.20%11.60%61.80%
Miscellaneous
Employees124179317
Shares Outstanding4.97 million26.37 million53.23 million133.44 million15.86 million
Next Earnings Date5/4/2020 (Estimated)N/A5/11/2020 (Estimated)5/20/2020 (Estimated)6/3/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel